Moeller, K. E., Kissack, J. C., Atayee, R. S., & Lee, K. C. (2017). Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens. MAYO CLINIC PROCEEDINGS, 92(5), 774-796. DOI:10.1016/j.mayocp.2016.12.007
Wolfe, M. E., Moeller, K. E., & Woods, B. (2017). Medical Students' Perceptions on the Role of Pharmacists. Journal of pharmacy practice, 897190017734764. DOI:10.1177/0897190017734764
Moeller, K. E., Sager, N. Mekles, T. Din, A. Genovese, A. Naveed, S. & Demo, A. (2016). Bad Weed: A Case of Prolonged Psychosis Secondary to Synthetic Cannabinoids. Kansas Medical Journal, 9(2), 43-44.
Moeller, K. E., Din, A. Wolfe, M. & Holmes, G. (2016). Psychotropic medication use in hospitalized patients with borderline personality disorder. Ment Health Clin , 6(2), 68-74.
Moeller, K. E., & Woods, B. (2015). Pharmacy Students' Knowledge and Attitudes Regarding Medical Marijuana. American journal of pharmaceutical education, 79(6), 85. DOI:10.5688/ajpe79685
Moeller, K. E. (2013). Favorable Pregnancy Outcomes Following Continual Intramuscular Lorazepam use in Late Pregnancy. Mental Health Clinician, 3(2), 92.
Moeller, K. E., Rigler, S. K., Mayorga, A. Nazir, N. & Shireman, T. I. (2011). Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance. Schizophrenia research, 126(1-3), 117-23. DOI:10.1016/j.schres.2010.11.015
Moeller, K. E., Shireman, T. I., Generali, J. Rigler, S. & Mayorga, A. (2010). Pharmacy students' knowledge of black box warnings. American journal of pharmaceutical education, 74(1), 5.